Moderators: Oliver Zivanovic, MD and Farr Nezhat, MD

Presentations:

• Further Analysis of the Phase 3, single-dose, open-label study to investigate the efficacy of pafolacianine sodium injection (OTL38) for intraoperative imaging during cytoreductive surgery of folate receptor positive ovarian cancer (Janos L. Tanyi, MD, PhD)
• Mapping Sentinel Lymph Nodes In Early-Stage Ovarian Cancer (MELISA) trial - A Further Step Towards Lymphadenectomy Replacement? (Nuria Agusti, MD)
• A randomized controlled trial of wound infiltration with liposomal bupivacaine with or without intrathecal analgesia in patients undergoing laparotomy for advanced gynecologic malignancy (Sean C. Dowdy, MD)
• Outcomes of low-volume metastatic disease in patients with early-stage squamous cell carcinoma undergoing sentinel lymph node biopsy; results from the International Vulvar Cancer Consortium (IVUCCO) (Dimitrios Nasioudis, MD)
• Distillation: Surgical Innovation: Driving Concepts from Discovery to the Bedside (Jamie Bakkum-Gamez, MD)
• Surgical Film: Laparoscopic en-bloc pelvic resection with rectosigmoid resection anastomosis for stage IIIB ovarian cancer (Jacopo J. Ferrari, MD)
• Overall Survival Following Interval Complete Gross Resection of Advanced Ovarian Cancer via Laparoscopy vs. Open Surgery: Analysis of the National Cancer Database (Judy Hayek, MD)
• Debate: MIS Interval Cytoreduction - CON (Kara Long Roche, MD, MSc)
• Debate: MIS Interval Cytoreduction- PRO (J. Alejandro Rauh-Hain, MD, MPH)
• Lifetime Achievement Award for Dennis Chi, MD and Presentation on: Surgical Training of Gynecologic Oncology Fellows: Long-term Trends and Implications for Future Education (Farr Nezhat, MD, Oliver Zivanovic, MD, and Dennis Chi, MD)